Innate and adaptive immunity: the understudied driving force of heart valve disease
Open accessThe DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
Calcific aortic valve disease (CAVD), and its clinical manifestation that is calcific aortic valve stenosis, is the leading cause for valve disease within the developed world, with no current pharmacological treatment available to delay or halt its progression. Characterized by progressive fibrotic remodelling and subsequent pathogenic mineralization of the valve leaflets, valve disease affects 2.5% of the western population, thus highlighting the need for urgent intervention. Whilst the pathobiology of valve disease is complex, involving genetic factors, lipid infiltration, and oxidative damage, the immune system is now being accepted to play a crucial role in pathogenesis and disease continuation. No longer considered a passive degenerative disease, CAVD is understood to be an active inflammatory process, involving a multitude of pro-inflammatory mechanisms, with both the adaptive and the innate immune system underpinning these complex mechanisms. Within the valve, 15% of cells evolve from haemopoietic origin, and this number greatly expands following inflammation, as macrophages, T lymphocytes, B lymphocytes, and innate immune cells infiltrate the valve, promoting further inflammation. Whether chronic immune infiltration or pathogenic clonal expansion of immune cells within the valve or a combination of the two is responsible for disease progression, it is clear that greater understanding of the immune systems role in valve disease is required to inform future treatment strategies for control of CAVD development.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Burden of valvular heart diseases: a population-based study
Nkomo, V. T., Gardin, J. M., Skelton, T. N., Gottdiener, J. S., Scott, C. G., & Enriquez-Sarano, M. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69208-8 · Cited by 4,881
Age-related clonal hematopoiesis associated with adverse outcomes
Jaiswal, S., Fontanillas, P., Flannick, J., Manning, A., Grauman, P. V., Mar, B. G., Lindsley, R. C., Mermel, C. H., Burtt, N., Chavez, A., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1408617 · Cited by 4,841
Flow-mediated endothelial mechanotransduction
Davies, P. F. (1995) · Physiological Reviews · doi:10.1152/physrev.1995.75.3.519 · Cited by 2,802
Clonal hematopoiesis and risk of atherosclerotic cardiovascular disease
Jaiswal, S., Natarajan, P., Silver, A. J., Gibson, C. J., Bick, A. G., Shvartz, E., McConkey, M., Gupta, N., Gabriel, S., Ardissino, D., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1701719 · Cited by 2,683 · cited 1×
“Unexpectedly, CHIP has been strongly associated with cardiovascular mortality and increased of coronary artery disease and progression of mineralization, with carriers four times more likely to experience myocardial infarction than non-carriers.(163,164) Unassociated to traditional cardiovascular risk factors, recent…”
BackgroundMacrophages in the Pathogenesis of Atherosclerosis
Moore, K. J., & Tabas, I. (2011) · Cell · doi:10.1016/j.cell.2011.04.005 · Cited by 2,669
Macrophage plasticity and polarization in tissue repair and remodelling
Mantovani, A., Biswas, S. K., Galdiero, M. R., Sica, A., & Locati, M. (2013) · The Journal of Pathology · doi:10.1002/path.4133 · Cited by 2,384 · cited 1×
“The blockage of IL-17 suggested to decrease plaque size and induce differentiation of M2 macrophages that promote inflammation resolution and secretion of anti-inflammatory cytokines and participates in the induction of Th2 response.(114) IL-17 is increased within CAVD patient plasma correlating with disease progressi…”
BackgroundClonal hematopoiesis associated with TET2 deficiency accelerates atherosclerosis development in mice
Fuster, J. J., MacLauchlan, S., Zuriaga, M. A., Polackal, M. N., Ostriker, A. C., Chakraborty, R., Wu, C.-L., Sano, S., Muralidharan, S., Rius, C., et al. (2017) · Science · doi:10.1126/science.aag1381 · Cited by 1,536 · cited 1×
“Mutations in either TET2 or DNMT3A are accompanied by increased inflammation due to the activation of the inflammasome complex, raising both IL-6 and IL-1b expressions, further highlighting CHIPs central role in inflammatory disease progression.(166) Mutations associated with CHIP have effects on immune effector cells…”
BackgroundPerforin and granzymes: function, dysfunction and human pathology
Voskoboinik, I., Whisstock, J. C., & Trapani, J. A. (2015) · Nature Reviews Immunology · doi:10.1038/nri3839 · Cited by 1,327 · cited 1×
“Finally, CD8þ cells release serineprotease granzymes and pore-forming perforin into the cleft between the membranes of the CD8þ cell and the target cell, resulting in breakdown of the membrane and targeting the cell for apoptosis.(152) Production of IFNc from this population has been suggested to drive the ectopic val…”
BackgroundNatural Killer Cells: Development, Maturation, and Clinical Utilization
Abel, A. M., Yang, C., Thakar, M. S., & Malarkannan, S. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01869 · Cited by 1,150
A Randomized Trial of Intensive Lipid-Lowering Therapy in Calcific Aortic Stenosis
Cowell, S. J., Newby, D. E., Prescott, R. J., Bloomfield, P., Reid, J., Northridge, D. B., & Boon, N. A. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043876 · Cited by 1,146 · cited 1×
“ering drug atorvastatin, attempting to halt or regress calcific aortic stenosis; however, researchers found no significantly beneficial outcome.(171)”
BackgroundGenetic Associations with Valvular Calcification and Aortic Stenosis
Thanassoulis, G., Campbell, C. Y., Owens, D. S., Smith, J. G., Smith, A. V., Peloso, G. M., Kerr, K. F., Pechlivanis, S., Budoff, M. J., Harris, T. B., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1109034 · Cited by 1,008
Freeman, R. V., & Otto, C. M. (2005) · Circulation · doi:10.1161/circulationaha.104.486738 · Cited by 1,006
Lindman, B. R., Clavel, M.-A., Mathieu, P., Iung, B., Lancellotti, P., Otto, C. M., & Pibarot, P. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.6 · Cited by 982 · cited 1×
“is the second most frequent cardiovascular disease after coronary artery disease, with a prevalence of 2% in the over 65 population.(8) With”
BackgroundRajamannan, N. M., Evans, F. J., Aikawa, E., Grande-Allen, K. J., Demer, L. L., Heistad, D. D., Simmons, C. A., Masters, K. S., Mathieu, P., O'Brien, K. D., et al. (2011) · Circulation · doi:10.1161/circulationaha.110.006767 · Cited by 842
Neutrophil-derived cytokines: facts beyond expression
Tecchio, C., Micheletti, A., & Cassatella, M. A. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00508 · Cited by 699 · cited 1×
“Neutrophils produce a broad range of cytokines which are notably hard to attribute directly to neutrophils, including but not limited to, colony stimulatory factors (G-CSF, GM-CST, IL-3), anti-inflammatory cytokines (IL-1RA, IL-4, TGFb1, TGFb2), immunoregulatory cytokines (INFa, IFNb, IFNc, IL-21, IL-21, IL-23, IL-27)…”
BackgroundMonoclonal T-cell proliferation and plaque instability in acute coronary syndromes.
Liuzzo, G., Goronzy, J. J., Yang, H., Kopecky, S. L., Holmes, D. R., Frye, R. L., & Weyand, C. M. (2000) · Circulation · doi:10.1161/01.cir.101.25.2883 · Cited by 552 · cited 1×
“The composition of the TCR repertoire differs between a stable atherosclerotic plaque, where the lymphocytes are suggested to be recruited via the lipid-stimulated macrophages(101,102) and predominantly derived from a CD4þCD28null effector T subset.(103,104) No shared clones within atherosclerosis and valve disease ly…”
BackgroundElyaman, W., Bradshaw, E. M., Uyttenhove, C., Dardalhon, V., Awasthi, A., Imitola, J., Bettelli, E., Oukka, M., van Snick, J., Renauld, J.-C., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0812530106 · Cited by 498
Li, Y., Schwabe, R. F., DeVries-Seimon, T., Yao, P. M., Gerbod-Giannone, M.-C., Tall, A. R., Davis, R. J., Flavell, R., Brenner, D. A., & Tabas, I. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m501759200 · Cited by 421
Sano, S., Oshima, K., Wang, Y., Katanasaka, Y., Sano, M., & Walsh, K. (2018) · Circulation Research · doi:10.1161/circresaha.118.313225 · Cited by 417
Nonclassical Patrolling Monocyte Function in the Vasculature
Thomas, G., Tacke, R., Hedrick, C. C., & Hanna, R. N. (2015) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.114.304650 · Cited by 367
Increased stem cell proliferation in atherosclerosis accelerates clonal hematopoiesis
Heyde, A., Rohde, D., McAlpine, C. S., Zhang, S., Hoyer, F. F., Gerold, J. M., Cheek, D., Iwamoto, Y., Schloss, M. J., Vandoorne, K., et al. (2021) · Cell · doi:10.1016/j.cell.2021.01.049 · Cited by 267
Schlotter, F., Halu, A., Goto, S., Blaser, M. C., Body, S. C., Lee, L. H., Higashi, H., DeLaughter, D. M., Hutcheson, J. D., Vyas, P., et al. (2018) · Circulation · doi:10.1161/circulationaha.117.032291 · Cited by 256 · cited 1×
“Cytokines play an essential role in inflammatory-mediated disease, with recent work highlighting the intricacies and interconnectivity of the immune system and the resident valve cells.(36) Unsurprisingly, CAVD and RHVD are similar cytokine and proteomic profiles as hypercholesterolaemia, myocardial infarction, and sy…”
BackgroundMacrophage heterogeneity in atherosclerotic plaques
Johnson, J. L., & Newby, A. C. (2009) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e3283309848 · Cited by 183 · cited 1×
“Within aortic valve disease, overwhelming production of inflammatory cytokines promoted a significant shift in the M1/M2 paradigm, with little to no M2 macrophages observed in vivo, highlighting the importance of the M1/M2 balance in management of pathogenic valve disease development.(85) High levels of oxidized lipop…”
BackgroundCD45 functions as a signaling gatekeeper in T cells
Courtney, A. H., Shvets, A. A., Lu, W., Griffante, G., Mollenauer, M., Horkova, V., Lo, W.-L., Yu, S., Stepanek, O., Chakraborty, A. K., et al. (2019) · Science Signaling · doi:10.1126/scisignal.aaw8151 · Cited by 161 · cited 1×
“Within the valve, 10–15% of the cells express the CD45þ lineage marker, which is crucial to activate phosphorylation and the subsequent downstream activation of TCR signalling.(97) T cells are well characterized in the aged and diseased valve.”
BackgroundEl Husseini, D., Boulanger, M.-C., Mahmut, A., Bouchareb, R., Laflamme, M.-H., Fournier, D., Pibarot, P., Bossé, Y., & Mathieu, P. (2014) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2014.02.014 · Cited by 150 · cited 2×
“Similarly, IL-6 has been implicated as a driving force in both pro-inflammatory T-cell maturation(44) and valve calcification,(45) with IL-6 silencing shown to inhibit mineralization in vitro.(46) As expected, cytokines deemed pro-inflammatory are also shown to promote calcification within VICs.”
BackgroundBroadley, I., Pera, A., Morrow, G., Davies, K. A., & Kern, F. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00195 · Cited by 103
The Endothelial-Mesenchymal Transition (EndMT) and Tissue Regeneration
Yu, W., Liu, Z., An, S., Zhao, J., Xiao, L., Gou, Y., Lin, Y., & Wang, J. (2014) · Current Stem Cell Research & Therapy · doi:10.2174/1574888x09666140213154144 · Cited by 61
Fujisaka, T., Hoshiga, M., Hotchi, J., Takeda, Y., Jin, D., Takai, S., Hanafusa, T., & Ishizaka, N. (2013) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2012.10.055 · Cited by 55 · cited 1×
“Furthermore, mast cell secretion of chymase converts angiotensin I to angiotensin II, which has been demonstrated to promote valvular thickening in mice.(61,62) Within aortic stenosis, correlation between mast cell prevalence and increase in osseous metaplasia was seen within the valve.”
BackgroundApoC-III is a novel inducer of calcification in human aortic valves
Schlotter, F., de Freitas, R. C. C., Rogers, M. A., Blaser, M. C., Wu, P.-J., Higashi, H., Halu, A., Iqbal, F., Andraski, A. B., Rodia, C. N., et al. (2021) · Journal of Biological Chemistry · doi:10.1074/jbc.ra120.015700 · Cited by 49
Clement, M., Raffort, J., Lareyre, F., Tsiantoulas, D., Newland, S., Lu, Y., Masters, L., Harrison, J., Saveljeva, S., Ma, M. K. L., et al. (2019) · Circulation Research · doi:10.1161/circresaha.119.315248 · Cited by 44
NETosis is associated with the severity of aortic stenosis: links with inflammation
Kopytek, M., Kolasa-Trela, R., Ząbczyk, M., Undas, A., & Natorska, J. (2019) · International Journal of Cardiology · doi:10.1016/j.ijcard.2019.03.047 · Cited by 33 · cited 1×
“In the case of aortic stenosis, NETs are present within aortic valve leaflets, accounting for 25% of total endothelium and sub-endothelium cell number, leading to increased endothelial permeability and activation of the coagulation cascade through platelet recruitment, enhancing the inflammatory process.(56) Further w…”
Background
Cited by
Calcific aortic valve disease: from molecular and cellular mechanisms to medical therapy
Kraler, S., Blaser, M. C., Aikawa, E., Camici, G. G., & Lüscher, T. F. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehab757 · Cited by 281
Song, G.-Y., Guo, X.-N., Yao, J., Lu, Z.-N., Xie, J.-H., wu, F., He, J., Fu, Z.-L., & Han, J. (2023) · BMC Cardiovascular Disorders · doi:10.1186/s12872-023-03311-x · Cited by 11
“CAVD is regarded as an active inflammatory process, similar to atherosclerosis, involving both the adaptive and the innate immune systems [34].”
BackgroundHouessou, U., Zamani, P., Manikpurage, H. D., Li, Z., Gaudreault, N., Dahmene, M., Dagenais, F., Couture, C., Clavel, M.-A., Pibarot, P., et al. (2025) · JACC: Basic to Translational Science · doi:10.1016/j.jacbts.2025.01.018 · Cited by 11
Metadata
- Authors
- Bartoli-Leonard, F., Zimmer, J., & Aikawa, E.
- Venue
- Cardiovascular Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2021-08-25
- Volume
- 117
- Issue
- 13
- Pages
- 2506-2524
- ISSN
- 0008-6363 (ISSN-L)
- 1755-3245
- OpenAlex
- W3194062313
- Cited by
- 81
- References
- 31
- FWCI
- 7.94
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.